Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies

Grants

Funding Acknowledgements

This study was supported in part by the European Community's Seventh Framework Programme under grant agreement number 223175 (HEALTH-F2-2009-223175). The individual Breast Cancer Association Consortium (BCAC) studies were funded by the following sources: Australian Breast Cancer Family Study (ABCFS) and Ontario Familial Breast Cancer Registry (OBCFR): National Cancer Institute (NCI), National Institutes of Health (NIH) under RFA CA-06-503 and through cooperative agreements with members of the Breast Cancer Family Registry (BCFR) and Principal Investigators, including Cancer Care Ontario (U01 CA69467), Northern California Cancer Center (U01 CA69417), and University of Melbourne (U01 CA69638).Breast Cancer in Galway Genetic Study (BIGGS): E.J.S. is funded by the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London.Copenhagen General Population Study (CGPS): The Chief Physician Johan Boserup and Lise Boserup Fund, the Danish Medical Research Council, and Copenhagen University Hospital, Herlev Hospital.Spanish National Cancer Centre Breast Cancer Study (CNIO-BCS): The Red Tematica de Investigacion Cooperativa en Cancer and grants from the Asociacion Espanola Contra Cancer and the Fondo de Investigacion Sanitario PI081120 to J.B. and PI081583 to R.L.M.).Gene Environment Interaction and Breast Cancer in Germany (GENICA): Federal Ministry of Education and Research (BMBF) Germany (01KW9975/5, 01KW9976/8, 01KW9977/0, and 01KW0114), the Robert Bosch Foundation of Medical Research, Stuttgart, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA), Bochum, as well as the Department of Internal Medicine, Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, Bonn, Germany.Genetic Epidemiology Study of Breast Cancer by Age 50 (GESBC): Deutsche Krebshilfe (70492) and the state of Baden-Wurttemberg through the Medical Faculty of the University of Ulm (P. 685).Helsinki Breast Cancer Study (HEBCS): The Helsinki University Central Hospital Research Fund, Academy of Finland (110663), the Finnish Cancer Society, and the Sigrid Juselius Foundation.Leuven Multidisciplinary Breast Centre (LMBC): European Union Framework Programme 6 Project LSHC-CT-2003-503297 (the Cancerdegradome) and by the 'Stichting tegen Kanker' (232-2008).Karolinska Breast Cancer Study (KARBAC): The Swedish Cancer Society, the Gustav V Jubilee Foundation, the Cancer Society in Stockholm, and the Bert von Kantzow Foundation.Kuopio Breast Cancer Project (KBCP): The Kuopio University Central EVO Research Fund, Academy of Finland, the Finnish Cancer Society, the University of Kuopio and EVO research funding of Vaasa Hospital District.Kathleen Cuningham Foundation Consortium for research into Familial Breast Cancer (kConFab): NHMRC (145684, 288704 and 454508), the National Breast Cancer Foundation, the National Health and Medical Research Council (NHMRC), the Queensland Cancer Fund, the Cancer Councils of New South Wales, Victoria, Tasmania and South Australia, and the Cancer Foundation of Western Australia. A. B. S. is supported by an NHMRC Senior Research Fellowship, and G. C.-T. by an NHMRC Senior Principal Research Fellowship.Mammary Carcinoma Risk Factor Investigation (MARIE): Deutsche Krebshilfe e. V. (70-2892-BR I), the Hamburg Cancer Society, and the German Cancer Research Center.Mayo Clinic Breast Cancer Study (MCBCS): NIH (CA122340), NIH recovery act (ARRA CA122340Z), and an NCI-sponsored Specialized Program Of Research Excellence (SPORE) Breast Cancer to the Mayo Clinic CA116201).Melbourne Collaborative Cohort Study (MCCS): The Cancer Council Victoria, VicHealth, and NHMRC (209057, 251533, 396414, 504711).Multiethnic Cohort (MEC): NIH (R01-CA63464 and R37-CA54281).Nurses Health Study (NHS): NIH (CA87969).Oulu Breast Cancer Study (OBCS): Finnish Cancer Foundation, the Sigrid Juselius Foundation, the Academy of Finland, the University of Finland, and Oulu University Hospital.Leiden University Medical Centre Breast Cancer Study (ORIGO): The Dutch Cancer Society.Polish Breast Cancer Study (PBCS): Intramural Research Program of US NIH, NCI, Division of Cancer Epidemiology and Genetics (DCEG).